VEGFR2/CD309 Antikörper (AA 20-125)
Kurzübersicht für VEGFR2/CD309 Antikörper (AA 20-125) (ABIN6254233)
Target
Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 20-125
-
Spezifität
- This antibody reacts with a 180 kDa protein and detects endogenous levels of total VEGFR2 protein.
-
Produktmerkmale
- Kinase insert receptor (a type III receptor tyrosine kinase)
-
Aufreinigung
- epitope affinity purified
-
Immunogen
- Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Handhabung
- The antibody solution should be gently mixed before use.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- For continuous use, store at 2-8 deg,C for one-two days. For extended storage, store in -20 deg,C freezer. Working dilution samples should be discarded if not used within 12 hours.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Andere Bezeichnung
- VEGFR2
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-